Evidence map›Paper›PMID 33074446›Full record

ArticleMolecular and cellular biochemistry2021

Myricitrin ameliorates cognitive deficits in MCAO cerebral stroke rats via histone acetylation-induced alterations of brain-derived neurotrophic factor.

Yang Gao, Bailiu Ya, Xiaojin Li, Yan Guo, Haiyan Yin

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Neurotrophic Natural Products.Progress in the chemistry of organic natural products · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yang GaoDepartment of Histology and Embryology, Basic Medical School of Jining Medical University, Jining, 272001, Shandong, China. gyjnmc2017@yeah.net.ORCID http://orcid.org/0000-0002-1119-9655
Bailiu YaDepartment of Physiology, Basic Medical School of Jining Medical University, Jining, 272001, Shandong, China.
Xiaojin LiDepartment of Histology and Embryology, Basic Medical School of Jining Medical University, Jining, 272001, Shandong, China.
Yan GuoDepartment of Histology and Embryology, Basic Medical School of Jining Medical University, Jining, 272001, Shandong, China.
Haiyan YinDepartment of Histology and Embryology, Basic Medical School of Jining Medical University, Jining, 272001, Shandong, China.

Funding

Innovative Research Group Project of the National Natural Science Foundation of China (CN) 81703490NSFC cultivation project of Jining Medical University JYP2018KJ06), The Undergraduate Innovation and Entrepreneurship Training Program of Jining Medical University cx2019026The Undergraduate Innovation and Entrepreneurship Training Program of Shandong S201910443008
6 · The paper itself

Abstract

The present study screened the effect of Myricitrin on cognitive deficits post-cerebral ischemic stroke and the involved mechanism. The rats were submitted to middle cerebral artery occlusion (MCAO) and were treated with sodium butyrate or Myricitrin (15 and 30 mg/kg) for 28 days. The spatial memory was studied by Morris water maze (MWM). After 4 weeks, the rats were euthanized and hippocampus region was utilized for neurochemical and biochemical changes. The extent of histone acetylation was studied by ELISA. Protein levels were analyzed by Western blot analysis. The mRNA levels were analyzed by polymerase chain reaction (PCR). In silico bioinformatics docking studies were done for target confirmation of Myricitrin. The treatment of Myricitrin showed improved memory in MWM compared to rats treated with vehicle, and the effects of Myricitrin were similar to sodium butyrate-treated rats. At a dose of 30 mg/kg Myricitrin, the histone deacetylase content was decreased, the expression levels of BDNF were increased, the levels of acetylated H3 and H4 along with Syn-I in the hippocampus region were over-expressed compared to control vehicle-treated rats. However, at low dose, i.e., 15 mg/kg Myricitrin failed to show alterations in biochemical as well as neurochemical markers. Docking studies suggested the BDNF and Sun-I as potential target proteins of Myricitrin. The cognitive ameliorating effect of Myricitrin post-cerebral ischemia stroke can be attributed to increased expression of BDNF and Syn-I and modulation of histone acetylation.

Indexed as

AcetylationAnimalsBrain-Derived Neurotrophic FactorButyric AcidCerebral CortexCognitive DysfunctionDisease Models, AnimalFlavonoidsHistamine AntagonistsHistone DeacetylasesHistonesInfarction, Middle Cerebral ArteryRatsRats, Sprague-DawleySpatial MemoryStrokeBrain-Derived Neurotrophic FactorButyric AcidFlavonoidsHistamine AntagonistsHistone DeacetylasesHistonesmyricitrinCerebral strokeCognitive deficitsHistone deacetylasesMyricitrin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.